Validation of Safety and Efficacy for Night Shift Therapy
1 other identifier
interventional
36
1 country
1
Brief Summary
The purpose of this study is to assess the accuracy of Night Shift in the detection of supine sleep and efficacy of vibro-tactile feedback in restricting supine sleep.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2013
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2013
CompletedFirst Submitted
Initial submission to the registry
January 8, 2014
CompletedFirst Posted
Study publicly available on registry
January 10, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2014
CompletedResults Posted
Study results publicly available
March 2, 2016
CompletedApril 1, 2016
June 1, 2014
8 months
January 8, 2014
April 28, 2014
March 4, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Percentage of Participants Who Completed the Study at 4 Weeks Without Adverse Events
Assess the potential for adverse events by evaluating whether more than 20% of participants chose to terminate the study prior to completing 4 weeks of therapy.
Four weeks
Evaluate Efficacy Based on a Change in Obstructive Sleep Apnea (OSA) Severity as a Result of Therapy
Determine the percentage of participants that exhibited at least a 50% reduction in OSA severity measured by AHI after 4 weeks of therapy.
30-days
Secondary Outcomes (8)
Confirmation That Night Shift Accurately Detects Supine Position
baseline and 4-weeks later at follow up
Evaluate Whether Night Shift Disrupts Sleep Such That Users Are Non-compliant
four weeks
Evaluate Whether Patients Adapt and Sleep Through the Position Therapy Feedback
four weeks
Evaluate Efficacy by Confirming Position Therapy Reduces Daytime Somnolence in Patients With Positional OSA
baseline and followup
Evaluate Impact of Positional Therapy on Quality of Life Scores
four weeks
- +3 more secondary outcomes
Study Arms (1)
Positional feedback
EXPERIMENTALDeliver therapy when the supine position is detected
Interventions
Application of vibrotactile feedback to the neck when the supine position is detected
Eligibility Criteria
You may qualify if:
- be between the age of 18 and 75 years,
- have been diagnosed with Obstructive Sleep Apnea (OSA) during polysomnography at a designated sleep center within 4 months of their enrollment,
- have not received treatment with any OSA therapy for more than 3 days within the past month,
- have an overall Apnea-Hypopnea Index (AHI) \> 10 and hypopneas requiring \>3% oxygen desaturation,
- having a non-supine Apnea-Hypopnea Index (AHI) \< 15 if Continuous Positive Airway Pressure has not been attempted,
- have a overall AHI divided by the non-supine AHI \> 1.5,
- had an Epworth Sleepiness Score of 5 or more at the time of diagnosis and at the start of therapy,
- Change in weight of no more than 5 pounds since the diagnostic PSG
- access to a computer and the Internet
- sleep is sometime between 8 P.M. to 9 A.M. Monday through Friday in the same bed
You may not qualify if:
- Neck, back or should pain which would impact ability to sleep laterally each night
- Body mass index \> 35
- suffering from neurological disorders which result in ticks or tremors
- diagnosed with congestive heart failure or chronic obstructive pulmonary disease
- suffered from a stroke within the previous 12 months
- taking or planning to take narcotic medications
- unfamiliar with use of internet browsers
- travel (i.e., foreign or cruise ship) which would limit internet or mail access
- planned medical procedures (e.g., surgery) which would limit device use during the scheduled 30-day study period or introduce the need for narcotic pain medications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Complete Sleep Solutions
Murrieta, California, 92563, United States
Related Publications (2)
Levendowski DJ, Seagraves S, Popovic D, Westbrook PR. Assessment of a neck-based treatment and monitoring device for positional obstructive sleep apnea. J Clin Sleep Med. 2014 Aug 15;10(8):863-71. doi: 10.5664/jcsm.3956.
PMID: 25126032BACKGROUNDLevendowski DJ, Veljkovic B, Seagraves S, Westbrook PR. Capability of a neck worn device to measure sleep/wake, airway position, and differentiate benign snoring from obstructive sleep apnea. J Clin Monit Comput. 2015 Feb;29(1):53-64. doi: 10.1007/s10877-014-9569-3. Epub 2014 Mar 6.
PMID: 24599632BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Daniel Levendowski
- Organization
- Advanced Brain Monitoring, Inc.
Study Officials
- PRINCIPAL INVESTIGATOR
Daniel J Levendowski, MBA
Advanced Brain Monitoring, Inc.
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 8, 2014
First Posted
January 10, 2014
Study Start
June 1, 2013
Primary Completion
February 1, 2014
Study Completion
February 1, 2014
Last Updated
April 1, 2016
Results First Posted
March 2, 2016
Record last verified: 2014-06